The AllianzIM U.S. Large Cap Buffer20 Mar ETF, which trades under the ticker MARW, is a "buffer" or "defined-outcome" exchange-traded fund. Rather than offering broad exposure to the S&P 500 in the conventional sense, MARW is engineered to give investors a more controlled way to participate in U.S. large-cap equities: it aims to cushion a portion of market declines in exchange for capping how much upside an investor can capture during a defined period. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.
MARW was launched on February 28, 2023, by Allianz Investment Management LLC, commonly known as AllianzIM, a subsidiary of the global insurer and asset manager Allianz. It is an actively managed fund, meaning portfolio managers make investment decisions rather than mechanically tracking an index, although the strategy itself follows a highly structured, rules-based framework.
The fund's investment objective is to match, at the end of each 12-month "outcome period," the share-price returns of the SPDR S&P 500 ETF Trust, up to a predetermined upside cap, while providing a buffer against the first 20% of losses in the underlying ETF. The "Mar" in the fund's name reflects that its outcome period resets each March. For example, an investor who holds shares for the entire outcome period is positioned to absorb the first 20% of SPY's decline before experiencing further losses, while upside participation is limited once the cap is reached.
To build this profile, the fund invests at least 80% of its net assets in instruments with economic characteristics similar to U.S. large-cap equities, primarily FLEX Options. FLEX Options are customized equity or index options contracts that trade on an exchange and allow the fund to tailor key terms such as strike prices, exercise styles, and expiration dates. This approach, combined with cash or other collateral, creates the buffered, capped return pattern.
Unlike a typical diversified equity ETF that may hold hundreds of stocks, MARW's portfolio holdings are highly concentrated. The fund generally reports only a handful of positions, almost entirely FLEX Options tied to the SPDR S&P 500 ETF Trust, along with a modest amount of cash collateral. This means the fund's underlying exposure broadly mirrors the sector composition of the S&P 500, where information technology has historically represented the largest weighting, followed by sectors such as financials, healthcare, and communication services.
The fund is non-diversified, a classification that signals it may concentrate its investments in fewer securities or instruments than a diversified fund. It has a net expense ratio of 0.74%, and it is not designed to pay regular distributions or dividends. Its value is primarily driven by the performance of its option positions over the course of the outcome period.
MARW attracts attention from investors seeking a measure of downside protection without fully exiting equity markets. Defined-outcome products like this one appeal to those who want U.S. large-cap sector exposure but are uncomfortable with the full volatility of the stock market. By buffering the first 20% of losses, the fund offers a form of risk management that can be useful for conservative investors, retirees, or those nearing a specific financial milestone.
The fund's structure also makes the outcome relatively predictable for a "buy and hold" investor over the full 12-month period. The trade-off is explicit: in exchange for the buffer, investors accept a cap on gains. This transparency about the potential range of outcomes is a key part of the product's appeal and sets it apart from conventional, uncapped equity funds.
Several factors are important to understand before investing in MARW. First, the buffer and cap apply only over the full outcome period. Investors who buy or sell shares mid-period will not necessarily receive the stated protection or cap, and the outcome depends heavily on the timing of their purchase. Second, the buffer is not a guarantee; losses beyond the 20% threshold are borne in full by the investor.
The fund is also subject to market risk tied to the underlying S&P 500 exposure, and its concentration in options and collateral makes it less diversified than a typical index ETF. There is no assurance the fund will achieve its objective, and an upside cap means the fund will underperform a direct S&P 500 investment during strong market rallies. Finally, its 0.74% expense ratio is a recurring cost that reduces net returns regardless of performance.
I often turn to Tickeron’s AI Screener when evaluating defined-outcome ETFs like this one. The platform lets me apply technical indicators, fundamentals, volatility measures, and AI-generated signals to compare options across industries and strategies. It helps surface ideas that align with specific risk parameters, which is useful when assessing how a fund like MARW fits into a broader portfolio context.
The AllianzIM U.S. Large Cap Buffer20 Mar ETF offers a distinctive investment profile: capped but buffered exposure to U.S. large-cap equities through a structured options strategy. Its defined-outcome design, low-concentration portfolio, and predictable annual reset cycle make it a specialized tool rather than a core equity holding. For investors who prioritize downside protection over full market participation, MARW represents a focused way to access the U.S. large-cap market with built-in risk parameters—provided they understand the trade-offs and timing requirements involved.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The 10-day moving average for MARW crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MARW as a result. In 14 of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 30%.
The Moving Average Convergence Divergence Histogram (MACD) for MARW turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 10 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 27%.
MARW moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MARW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 29%.
The Aroon Indicator for MARW entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where MARW advanced for three days, in 177 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
MARW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.